CMS IPPS Proposed Rule Includes Higher Paying DRG For Brain Aneurysms
This article was originally published in The Gray Sheet
Boston Scientific will try to persuade CMS to create a separate diagnosis related group for unruptured brain aneurysms that would correspond with a newly created DRG for ruptured brain aneurysms
You may also be interested in...
CMS' decision to lower the cost threshold for new devices to qualify for technology "add-on" payments under the IPPS assumes that the number of applications for the additional reimbursement will remain sparse
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.